Literature DB >> 23726508

Side effects of antidepressants during long-term use in a naturalistic setting.

Pierre M Bet1, Jacqueline G Hugtenburg, Brenda W J H Penninx, Witte J G Hoogendijk.   

Abstract

Side effects of antidepressants are usually underreported in clinical trials and large scale naturalistic studies are restricted to six months of use. We examined the prevalence and nature of patient-perceived side effects and their determinants during long-term antidepressant use in a naturalistic setting. Subjects, aged 19 to 67 years, in the Netherlands Study of Depression and Anxiety were recruited from primary care and specialized mental health care covered 927 cases of single antidepressant use. In 64% of cases, on average, 2.9 side effects were reported. The number of side effects was higher when subjects had higher depression severity (OR=1.28; p=0.002), three or more psychiatric diagnoses (OR=1.97; p=0.02), higher dose (OR=1.44; p=0.006) and was lower when subjects were older (OR=0.83; p=0.02) and had longer duration of use (OR=0.94; p=0.04). Tricyclic antidepressants were associated with more side effects (OR=2.52; p=0.003) and, particularly, more anticholinergic effects, like dry mouth and constipation, as compared to selective serotonin reuptake inhibitors. Venlafaxine showed more profuse sweating (OR=1.79; p=0.007), whereas mirtazapine showed more weight gain and less sexual dysfunction (OR=0.36; p=0.03), as compared to selective serotonin reuptake inhibitors. Weight gain was associated with female gender (OR=1.76; p=0.004) and duration of use (OR=1.06; p=0.03). We show that antidepressant side effect, known from short-term studies, persist during long-term use and are associated with depression severity and antidepressant dose. A novel finding was that venlafaxine is associated with more profuse sweating and that weight gain appeared more specific in female users. Clinicians should be aware that, during long-term antidepressant use, side effects are common and persistent.
Copyright © 2013 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Antidepressants; Anxiety; Depression; Naturalistic setting; Side effects

Mesh:

Substances:

Year:  2013        PMID: 23726508     DOI: 10.1016/j.euroneuro.2013.05.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  55 in total

1.  Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression.

Authors:  Suene Vanessa da Silva Souza; Priscila Batista da Rosa; Vivian Binder Neis; Júlia Dubois Moreira; Ana Lúcia S Rodrigues; Morgana Moretti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-28       Impact factor: 3.000

Review 2.  Clozapine and Gastrointestinal Hypomotility.

Authors:  Dan Cohen
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

3.  [Incidence of constipation in patients with outpatient opioid therapy].

Authors:  S Tafelski; T Beutlhauser; F Bellin; E Reuter; T Fritzsche; C West; M Schäfer
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

4.  Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice.

Authors:  Lucimar M Pinto Brod; Mariana G Fronza; Jaqueline Pinto Vargas; Diogo S Lüdtke; César Augusto Brüning; Lucielli Savegnago
Journal:  Psychopharmacology (Berl)       Date:  2016-12-19       Impact factor: 4.530

5.  Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009.

Authors:  R Park; S Mikami; J LeClair; A Bollom; C Lembo; S Sethi; A Lembo; M Jones; V Cheng; E Friedlander; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2015-03-22       Impact factor: 3.598

6.  A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort.

Authors:  P M Bet; E C Verbeek; Y Milaneschi; D B M Straver; T Uithuisje; M R Bevova; J G Hugtenburg; P Heutink; B W J H Penninx; W J G Hoogendijk
Journal:  Pharmacogenomics J       Date:  2015-05-19       Impact factor: 3.550

7.  Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.

Authors:  Renske C Bosman; Klaas M Huijbregts; Peter Fm Verhaak; Henricus G Ruhé; Harm Wj van Marwijk; Anton Jlm van Balkom; Neeltje M Batelaan
Journal:  Br J Gen Pract       Date:  2016-08-15       Impact factor: 5.386

8.  Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care.

Authors:  Carolien Wentink; Marloes J Huijbers; Peter Lbj Lucassen; Annoek van der Gouw; Cornelis Kramers; Jan Spijker; Anne Em Speckens
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

9.  Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Authors:  Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

10.  Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Authors:  Christian A Webb; Madhukar H Trivedi; Zachary D Cohen; Daniel G Dillon; Jay C Fournier; Franziska Goer; Maurizio Fava; Patrick J McGrath; Myrna Weissman; Ramin Parsey; Phil Adams; Joseph M Trombello; Crystal Cooper; Patricia Deldin; Maria A Oquendo; Melvin G McInnis; Quentin Huys; Gerard Bruder; Benji T Kurian; Manish Jha; Robert J DeRubeis; Diego A Pizzagalli
Journal:  Psychol Med       Date:  2018-07-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.